Erratum: Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in mice (Journal of Clinical Investigation (2011) 121, 6 (2470-2479) DOI: 10.1172/JCI43881);Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in mice

Journal of Clinical Investigation

Volumn 121, Issue 6, 2011, Pages 2470-2479

  Clauss, Matthias ^a   Voswinckel, Robert ^b   Rajashekhar, Gangaraju ^a   Sigua, Ninotchka L ^a   Fehrenbach, Heinz ^c   Rush, Natalia I ^a   Schweitzer, Kelly S ^a   Yildirim, Ali Ö ^d   Kamocki, Krzysztof ^a   Fisher, Amanda J ^a   Gu, Yuan ^a   Safadi, Bilal ^a   Nikam, Sandeep ^b   Hubbard, Walter C ^e   Tuder, Rubin M ^f   Twigg III, Homer L ^a   Presson, Robert G ^a   Sethi, Sanjay ^g   Petrache, Irina ^a,h  

^a INDIANA UNIVERSITY   (United States)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c RESEARCH CENTER BORSTEL   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CIGARETTE SMOKE; ENDOTHELIAL MONOCYTE ACTIVATING PROTEIN 2; NEUTRALIZING ANTIBODY; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME RELEASE; ENZYME SYNTHESIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS; LUNG COMPLIANCE; LUNG EMPHYSEMA; LUNG ENDOTHELIUM; LUNG FUNCTION; LUNG LAVAGE; LUNG STRUCTURE; MACROPHAGE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SMALL AIRWAY DISEASE; TRANSGENIC MOUSE; UPREGULATION;

EID: 79957880378     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI64369     Document Type: Erratum

References (50)

1. Tuder RM, Petrache I, Elias JA, Voelkel NF, Henson PM. Apoptosis and emphysema: the missing link. Am J Respir Cell Mol Biol. 2003;28(5):551-554. (Pubitemid 36543401)
2. Park JW, Ryter SW, Choi AM. Functional significance of apoptosis in chronic obstructive pulmonary disease. Copd. 2007;4(4):347-353. (Pubitemid 350135869)
3. Giordano RJ, et al. Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse. J Biol Chem. 2008; 283(43):29447-29460.
4. Kao J, et al. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J Biol Chem. 1992;267(28):20239-20247.
5. Kao J, et al. Characterization of a novel tumor-derived cytokine. Endothelial- monocyte activating polypeptide II. J Biol Chem. 1994;269(40):25106-25119.
6. Schwarz MA, et al. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J Exp Med. 1999;190(3):341-354.
7. Berger AC, et al. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis. Microvasc Res. 2000;60(1):70-80. (Pubitemid 30456829)
8. Hou Y, et al. Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3. Exp Hematol. 2006;34(8):1125-1132. (Pubitemid 44080393)
9. Wakasugi K, Schimmel P. Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase. J Biol Chem. 1999; 274(33):23155-23159.
10. Kao J, et al. A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response. J Biol Chem. 1994;269(13):9774-9782.
11. Quevillon S, Agou F, Robinson JC, Mirande M. The p43 component of the mammalian multisynthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine. J Biol Chem. 1997;272(51):32573-32579. (Pubitemid 28011946)
12. Knies UE, et al. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Proc Natl Acad Sci U S A. 1998;95(21):12322-12327.
13. Barnett G, Jakobsen AM, Tas M, Rice K, Carmichael J, Murray JC. Prostate adenocarcinoma cells release the novel proinflammatory polypeptide EMAP-II in response to stress. Cancer Res. 2000; 60(11):2850-2857. (Pubitemid 30395805)
14. Matschurat S, et al. Regulation of EMAP II by Hypoxia. Am J Pathol. 2003;162(1):93-103. (Pubitemid 36041992)
15. Journeay WS, Janardhan KS, Singh B. Expression and function of endothelial monocyte-activating polypeptide-II in acute lung inflammation. Inflamm Res. 2007;56(5):175-181. (Pubitemid 46985836)
16. Behrensdorf HA, van de Craen M, Knies UE, Vandenabeele P, Clauss M. The endothelial monocyteactivating polypeptide II (EMAP II) is a substrate for caspase-7. FEBS Lett. 2000;466(1):143-147. (Pubitemid 30050701)
17. Wakasugi K, Schimmel P. Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science. 1999;284(5411):147-151. (Pubitemid 29282068)
18. Zhang FR, Schwarz MA. Pro-EMAP II is not primarily cleaved by caspase-3 and -7. Am J Physiol Lung Cell Mol Physiol. 2002;282(6):L1239-L1244. (Pubitemid 34654579)
19. Liu J, Schwarz MA. Identification of protease-sensitive sites in human endothelial-monocyte activating polypeptide II protein. Exp Cell Res. 2006; 312(12):2231-2237. (Pubitemid 43928941)
20. Shalak V, Kaminska M, Mitnacht-Kraus R, Vandenabeele P, Clauss M, Mirande M. The EMAPII cytokine is released from the mammalian multisynthetase complex after cleavage of its p43/proEMAPII component. J Biol Chem. 2001;276(26):23769- 23776.
21. Shapiro SD. Proteinases in chronic obstructive pulmonary disease. Biochem Soc Trans. 2002; 30(2):98-102.
22. Clark JC, et al. FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. Am J Physiol Lung Cell Mol Physiol. 2001;280(4):L705-L715.
23. Qu P, et al. Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease. Lung Cancer. 2009; 63(3):341-347.
24. Knies UE, Kroger S, Clauss M. Expression of EMAP II in the developing and adult mouse. Apoptosis. 2000;5(2):141-151. (Pubitemid 30399388)
25. Bartalesi B, et al. Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants. Eur Respir J. 2005;25(1):15-22. (Pubitemid 40207726)
26. Rajashekhar G, et al. A monoclonal rat anti-mouse EMAP II antibody that functionally neutralizes pro- and mature-EMAP II in vitro. J Immunol Methods. 2009;350(1-2):22-28.
27. Shen HH, Xu F, Zhang GS, Wang SB, Xu WH. CCR3 monoclonal antibody inhibits airway eosinophilic inflammation and mucus overproduction in a mouse model of asthma. Acta Pharmacol Sin. 2006; 27(12):1594-1599. (Pubitemid 44813897)
28. Kasahara Y, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000;106(11):1311-1319.
29. Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol. 2003; 28(5):555-562. (Pubitemid 36543402)
30. Petrache I, et al. {alpha}-1 Antitrypsin Inhibits Caspase-3 Activity, Preventing Lung Endothelial Cell Apoptosis. Am J Pathol. 2006;169(4):1155-1166. (Pubitemid 351194353)
31. Fehrenbach A, et al. Stereological estimation of the volume weighted mean volumes of alveoli and acinar pathways in the rat lung to characterise alterations after ischaemia/reperfusion. J Anat. 1999; 194(pt 1):127-135. (Pubitemid 29126702)
32. Knudsen L, Weibel ER, Gundersen HJ, Weinstein FV, Ochs M. Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. J Appl Physiol. 2010;108(2):412-421.
33. Caserta TM, Smith AN, Gultice AD, Reedy MA, Brown TL. Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis. 2003;8(4):345-352. (Pubitemid 36935206)
34. Sisson TH, et al. Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice. Am J Respir Cell Mol Biol. 2006;34(5):552-560.
35. Rossiter HB, Scadeng M, Tang K, Wagner PD, Breen EC. Doxycycline treatment prevents alveolar destruction in VEGF-deficient mouse lung. J Cell Biochem. 2008;104(2):525-535. (Pubitemid 351671641)
36. Awasthi N, Schwarz MA, Verma V, Cappiello C, Schwarz RE. Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling. Lab Invest. 2009;89(1):38-46.
37. Petrache I, et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med. 2005;11(5):491-498. (Pubitemid 40685971)
38. Grumelli S, et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 2004;1(1):e8.
39. Saetta M, et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;165(10):1404-1409. (Pubitemid 34522945)
40. Costa C, Rufino R, Traves SL, Lapa ESJR, Barnes PJ, Donnelly LE. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. Chest. 2008;133(1):26-33.
41. Petrache I, et al. Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide. Am J Physiol Lung Cell Mol Physiol. 2008; 295(1):L44-L53.
42. Adair-Kirk TL, et al. Distal airways in mice exposed to cigarette smoke: Nrf2-regulated genes are increased in Clara cells. Am J Respir Cell Mol Biol. 2008; 39(4):400-411.
43. Marvin MR, et al. A novel tumor-derived mediator that sensitizes cytokine-resistant tumors to tumor necrosis factor. J Surg Res. 1996;63(1):248-255. (Pubitemid 26197730)
44. Schwarz MA, Zhang F, Gebb S, Starnes V, Warburton D. Endothelial monocyte activating polypeptide II inhibits lung neovascularization and airway epithelial morphogenesis. Mech Dev. 2000;95(1-2):123-132. (Pubitemid 30440800)
45. Quintos-Alagheband ML, White CW, Schwarz MA. Potential role for antiangiogenic proteins in the evolution of bronchopulmonary dysplasia. Antioxid Redox Signal. 2004;6(1):137-145. (Pubitemid 38063985)
46. Warburton D, Schwarz M, Tefft D, Flores-Delgado G, Anderson KD, Cardoso WV. The molecular basis of lung morphogenesis. Mech Dev. 2000;92(1):55-81. (Pubitemid 30125962)
47. Rajashekhar G, et al. A monoclonal rat anti-mouse EMAP II antibody that functionally neutralizes pro- and mature-EMAP II in vitro. J Immunol Methods. 2009;350(1-2):22-28.
48. Cavarra E, et al. Effects of cigarette smoke in mice with different levels of alpha(1)-proteinase inhibitor and sensitivity to oxidants. Am J Respir Crit Care Med. 2001;164(5):886-890. (Pubitemid 32881929)
49. Tuder RM, et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol. 2003;29(1):88-97. (Pubitemid 36783320)
50. Castro CM, Yang Y, Zhang Z, Linnoila RI. Attenuation of pulmonary neuroendocrine differentiation in mice lacking Clara cell secretory protein. Lab Invest. 2000;80(10):1533-1540.